4.3 Article

Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas?

Journal

JOURNAL OF CLINICAL NEUROSCIENCE
Volume 16, Issue 6, Pages 854-855

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2008.09.005

Keywords

Temozolomide; Glioma; Glioblastoma multiforme

Ask authors/readers for more resources

Temozolomide (TMZ) is an alkylating agent used in the management of gliomas. Although TMZ is generally safe and acute toxicity is well documented, there are limited data on long-term toxicities. We present three patients with glioma; all patients started on TMZ after having progressed following primary treatment. These patients have continued TMZ for 5 years, 7 years and 8 years respectively. So far they have had no serious side effects. We discuss these patients while raising the question of prolonged TMZ use. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available